January 22, 2018 — Baxter International Inc. announced the U.S. Food and Drug Administration (FDA) approval of ...
September 12, 2017 — Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with ...
May 16, 2016 — A study using a stem cell therapy to treat challenging refractory angina (RA) patients demonstrated ...
March 5, 2012 — Baxter International Inc. announced that it initiated a phase III pivotal clinical trial to evaluate the ...
June 17, 2011 — KLAS today announced the release of their highly anticipated "2011 Top 20 Best in KLAS Awards: Medical ...
April 21, 2011 – Baxter International has entered into a definitive agreement to acquire privately-held Prism ...
Baxter Healthcare Corp. received FDA 510(k) clearance for its needleless V-Link Luer-activated device (LAD), an IV ...
Baxter Healthcare Corp. received FDA approval in December for the GELFOAM Plus Hemostasis Kit (absorbable gelatin sponge ...